Today from
The event can be followed using the following link: https://tv.streamfabriken.com/addlife-capital-markets-day-2023
During the Capital Markets Day today
Based on the current position of the business, the market development and outlook,
- Profit growth (measured in EBITA) for the long-term will be 15 percent per year
- Profitability will be at least 45 per cent, measured as the ratio between EBITA and working capital (P/WC)
- Dividend policy: The target is a dividend corresponding to 30-50 percent of profit after tax. Consideration is taken to investment needs and other factors of importance
Karin Fischer andMattias Bengtsson will be presentingBiolin Scientific , a company withinAddLife since 2016, providing advanced surface science products and solutions.Carlos Pinto will be presenting MBA, a company withinAddLife since 2022, and a provider of a broad range of products in surgery, anaesthesia and other related products, as well as a market leader in advanced services.
For
- European coverage:
AddLife aims to further strengthen the business and extend the product portfolio by leveraging its unique and recently expanded European coverage, making theAddLife companies even more attractive to its partners. -
Digital solutions:
AddLife aims to increase its offering of digital solutions that are or can be combined with other products and services in the portfolio, as well as using digital solutions to improve the efficiency of the business operation. -
Value and productivity selling:
AddLife aims to identify an increasing amount of product and service offerings that support health providers to adopt more efficient processes and perform more procedures with available staffing and thereby also help reducing decreasing patient waiting lists. -
Service offering:
AddLife aims to increase the service offering to strengthen customer relationships, differentiation and pricing power. -
Own products:
AddLife aims to leverage potential for current and new own products to be sold and marketed through internal market channels. - Acquisitions in selected segments: The Group continues to actively look for acquisition candidates in selected segments and geographies, preferable smaller and mid-sized add-on or standalone acquisitions with attractive margins.
For the period 2021 to 2025, the
The Group has also identified and will present prioritised growth segments in all of our business units. The segments include among others, Microbiology in
Referring to its strategy,
"The starting point of our strategy is our established and proven vision, business model and strategic direction. Our increased size and strengthened European presence provide additional opportunities to expand our business. We are addressing these opportunities with our new strategic initiatives. We have also identified prioritized segments that will drive accelerated growth and further improve our profitability."
Overview of the agenda of the Capital Markets Day
- AddLife Business Model -
Fredrik Dalborg , CEOAddLife - Financials - Christina Rubenhag, CFO AddLife
- Performance Management - Peter Simonsbacka, Chief Commercial Officer AddLife
-
Case study:
Biolin Scientific -Karin Fischer CEOBiolin Scientific , Mattias Bengtsson Business Unit Leader Biomedical & Research,AddLife -
Panel Discussion:
AddLife as an owner -
Case Study: MBA -
Carlos Pinto , CEO MBA -
Future strategy & summary -
Fredrik Dalborg , CEOAddLife
In addition, there will be Q&A sessions as well as opportunities to look at products and interact with
For more information, contact;
Christina Rubenhag, CFO, christina.rubenhag@add.life, +46 70 546 72 22
www.add.life
This information is information that
https://news.cision.com/addlife/r/addlife-reiterates-its-financial-targets-and-identifies-prioritized-growth-segments,c3835523
https://mb.cision.com/Main/13919/3835523/2296141.pdf
(c) 2023 Cision. All rights reserved., source